Contents
1. The short answer
A freezer excursion — product stored below −15 °C (or below −60 °C for ultra-low chain) rising into or through a warmer band — is assessed against the product's own stability data, not a generic rule. The decision to release, quarantine or reject depends on how far, how long, and how sensitive the product is — and on whether a freeze/thaw boundary was crossed, which for many biologics is disqualifying on its own.
2. The assessment checklist
Work through these in order. Stop and quarantine at any step you cannot answer from records.
| # | Step | What to confirm |
|---|---|---|
| 1 | Secure & quarantine | Move affected units to a controlled hold; do not distribute pending disposition. |
| 2 | Reconstruct the profile | Pull the logger trace: start/end time, minimum temperature reached, total time outside the label range, number of freeze/thaw cycles. |
| 3 | Identify the registered condition | Label storage (e.g. −20 °C ± 5 °C, or 2–8 °C for a chilled product that froze). The excursion direction matters. |
| 4 | Check freeze sensitivity | Does the product's stability file demonstrate freeze/thaw tolerance? Proteins, vaccines, emulsions and suspensions are frequently freeze-labile. |
| 5 | Quantify impact | Compare the excursion to supporting stability studies (cycling data, short-term excursion studies). Where kinetics apply, compute stability-budget consumption. |
| 6 | Consult the marketing authorisation | Some dossiers pre-define allowed excursions; if the event is inside that envelope, cite it. If not, escalate. |
| 7 | Decide & sign | Release / conditional / reject, decided by the authorized person (QP), with the evidence attached. Record in the QMS. |
| 8 | CAPA | Root-cause the excursion (equipment, packout, transit) and act — the disposition closes the batch, CAPA closes the cause. |
3. Why frozen is different from chilled
For a chilled (2–8 °C) product, a warm excursion consumes shelf life gradually and is often modellable with Arrhenius kinetics. A freeze event is a phase change, not a rate change: ice crystal formation can shear proteins, crack emulsions, or break primary packaging — damage that no average temperature captures and that may be irreversible after a single cycle. Conversely, a product registered frozen (−20 °C) that warms into 2–8 °C has left its registered state and must be assessed against whatever refrigerated-hold data exists, if any.
This is why "the average was in range" fails for frozen product: the average can sit comfortably inside the band while a disqualifying freeze/thaw boundary was crossed for minutes.
4. What an inspector expects to see
- The actual logger trace, not a summary statistic — with calibration status of the logger.
- An explicit statement of the registered storage condition and the delta.
- The stability data the disposition relies on, cited specifically (study, timepoint, condition).
- A signed disposition by the authorized person, dated, with rationale (ALCOA+).
- Reproducibility: another reviewer, given the same inputs, reaches the same decision.
5. The two most common mistakes
Mistake 1 — averaging away the event. Reporting an MKT or mean that "proves" the batch stayed in range, when the profile contains a brief but disqualifying freeze. The assessment is the profile, not the average. (See our companion article on why MKT can mask spikes.)
Mistake 2 — deciding without documented stability data. "It was only two hours" is a feeling, not evidence. If the stability file does not support the excursion, the honest disposition is quarantine and escalation, not release.
This is exactly where Synlogica Terminus (Terminus M4, Quality) helps: it reconstructs the profile from the logger file, compares it to the product's stability model, computes the impact with a stated confidence interval, and assembles a sealed, reproducible decision package — leaving the binding release call to your QP. The excursion decision package white paper shows the full anatomy.
6. FAQ
Is a single freeze/thaw cycle always disqualifying?
No — it depends on the product. Many frozen products tolerate defined cycles, demonstrated in stability studies. But for freeze-labile biologics without supporting cycling data, a single event below the freezing boundary is commonly cause for rejection. The stability file decides, not a rule of thumb.
Can we use MKT for a freezer excursion?
MKT is designed for degradation that follows Arrhenius kinetics — it does not describe freeze damage, which is a phase-change effect. Use MKT (if at all) only for the warm portions of a profile, and never let it hide a freeze event.
Who signs the final disposition?
The authorized person — in EU GMP, the Qualified Person (QP). Software and colleagues can prepare and recommend; the binding release decision and signature rest with the QP, recorded in the quality system.
7. References
- EU Guidelines on Good Distribution Practice (2013/C 343/01), Chapter 9 — Transportation.
- EU GMP Annex 1 (2022) and Annex 15 — qualification and control of storage conditions.
- ICH Q1A(R2) — Stability Testing; ICH Q5C — Stability of Biotechnological Products.
- USP General Chapter <1079> — Storage and Transportation of Finished Drug Products.